The endocannabinoid system as a target for the treatment of motor dysfunction

per Fernández-Ruiz, Javier
Publicat 2009

The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes

per Fernández‐Ruiz, Javier
Publicat a Br J Pharmacol (2018)

Cannabinoid signaling system: Does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?

per Gómez, María, Hernández, Mariluz, Fernández-Ruiz, Javier
Publicat 2008

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

per Fernández‐Ruiz, Javier, Hernández, Mariluz, Ramos, José A.
Publicat a CNS Neurosci Ther (2010)

Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications

per Fernández-Ruiz, Javier, Moro, María A., Martínez-Orgado, José
Publicat a Neurotherapeutics (2015)

Effects of cannabinoids on adrenaline release from adrenal medullary cells

per Niederhoffer, Nathalie, Hansen, Henrik H, Fernandez-Ruiz, Javier J, Szabo, Bela
Publicat 2001

Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia

per García, Concepción, Palomo‐Garo, Cristina, Gómez‐Gálvez, Yolanda, Fernández‐Ruiz, Javier
Publicat a Br J Pharmacol (2015)

Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors

per Valdeolivas, Sara, Satta, Valentina, Pertwee, Roger G., Fernández-Ruiz, Javier, Sagredo, Onintza
Publicat 2012

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

per Valdeolivas, Sara, Sagredo, Onintza, Delgado, Mercedes, Pozo, Miguel A., Fernández-Ruiz, Javier
Publicat a Int J Mol Sci (2017)

Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1(G93A) Transgenic Mice and Evaluation of a Sativex(®)‐like Combination of Phytocannabinoids: Interest for...

per Moreno‐Martet, Miguel, Espejo‐Porras, Francisco, Fernández‐Ruiz, Javier, de Lago, Eva
Publicat a CNS Neurosci Ther (2014)

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease

per Burgaz, Sonia, García, Concepción, Gómez-Cañas, Maria, Muñoz, Eduardo, Fernández-Ruiz, Javier
Publicat a Molecules (2019)

SHORT-TERM EXPOSURE TO ALCOHOL IN RATS AFFECTS BRAIN LEVELS OF ANANDAMIDE, OTHER N-ACYLETHANOLAMINES AND 2-ARACHIDONOYL-GLYCEROL

per Rubio, Marina, McHugh, Douglas, Fernández-Ruiz, Javier, Bradshaw, Heather, Walker, J. Michael
Publicat 2007

Targeting Cannabinoid CB(2) Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

per Navarro, Gemma, Morales, Paula, Rodríguez-Cueto, Carmen, Fernández-Ruiz, Javier, Jagerovic, Nadine, Franco, Rafael
Publicat a Front Neurosci (2016)

Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease

per Burgaz, Sonia, García, Concepción, Gómez-Cañas, María, Rolland, Alain, Muñoz, Eduardo, Fernández-Ruiz, Javier
Publicat a Molecules (2021)

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Ta...

per Gómez-Ruiz, María, Rodríguez-Cueto, Carmen, Luna-Piñel, Eva, Hernández-Gálvez, Mariluz, Fernández-Ruiz, Javier
Publicat a Front Mol Neurosci (2019)

Pharmacokinetics of Sativex(®) in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

per Fernández-Trapero, María, Pérez-Díaz, Carmen, Espejo-Porras, Francisco, de Lago, Eva, Fernández-Ruiz, Javier
Publicat a Biomolecules (2020)

Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias

per Rodríguez-Cueto, Carmen, Benito, Cristina, Fernández-Ruiz, Javier, Romero, Julián, Hernández-Gálvez, Mariluz, Gómez-Ruiz, María
Publicat 2014

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

per Fernández-Ruiz, Javier, Sagredo, Onintza, Pazos, M Ruth, García, Concepción, Pertwee, Roger, Mechoulam, Raphael, Martínez-Orgado, José
Publicat 2013

Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

per González, Sara, Valenti, Marta, de Miguel, Rosario, Fezza, Filomena, Fernández-Ruiz, Javier, Di Marzo, Vincenzo, Ramos, José A
Publicat 2004

Targeting glial cannabinoid CB(2) receptors to delay the progression of the pathological phenotype in TDP‐43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis

per Espejo‐Porras, Francisco, García‐Toscano, Laura, Rodríguez‐Cueto, Carmen, Santos‐García, Irene, de Lago, Eva, Fernandez‐Ruiz, Javier
Publicat a Br J Pharmacol (2018)